Abiopharma

News list

Director BAYLESS KATHLEEN A 🟢 acquired 10.4K shares of Amprius Technologies, Inc. (AMPX) Transaction Date: Jun 12, 2026 | Filing ID: 000005

Full text

News bot June 16, 2026, 10:03 p.m.
🔍 BAYLESS KATHLEEN A (Director)

Company: Amprius Technologies, Inc. (AMPX)

Report Date: 2026-06-12
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 10,423
Detailed Transactions and Holdings:
- Acquired 10,423 shares of Common stock (Direct)
  Date: 2026-06-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 216,120.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: The securities are represented by restricted stock units. Each restricted stock unit represents the reporting person's right to receive one share of issuer's common stock. 100% of the restricted stock units vest on the earlier of (i) the one-year anniversary of the date the restricted stock units were granted and (ii) the day before the next annual meeting of stockholders, subject to the reporting person's continued service as of the vesting date.
- F2: Includes 10,423 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock, subject to the applicable vesting schedule and conditions of each restricted stock unit.
- REMARKS: Exhibit 24-Power of Attorney